Suvretta Capital Management, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.4 Billion
- Q4 2024
A detailed history of Suvretta Capital Management, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 6,783,091 shares of EYPT stock, worth $41.7 Million. This represents 2.1% of its overall portfolio holdings.
Number of Shares
6,783,091
Previous 5,175,823
31.05%
Holding current value
$41.7 Million
Previous $41.4 Million
22.2%
% of portfolio
2.1%
Previous 1.63%
Shares
15 transactions
Others Institutions Holding EYPT
# of Institutions
156Shares Held
72.4MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$51.2 Million4.9% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$35.4 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$25.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$23.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$23.2 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $210M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...